These solid results indicate that HZ has a promising bioactivity in regulating obesity and insulin sensitivity, which may have potential for clinical application in preventing from hepatic steatosis and insulin resistance. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.